Close Many team members at Unicorn Nest are Ukrainians affected by Russian aggression. We do our best to solve any issues and answer your questions in the shortest possible time frames but some delays are possible.

HighCape Partners

Investor type Micro VC
Founders Kevin Rakin Matt Zuga Matt Zuga


Unlock datapoints

Portfolio analytics



News & Media

Add fund to favorites
Save this fund for later to form your own custom list of funds
This summary is composed by our algorithm based on the analysis of the deals. If you think that some of this information is not accurate, please let us know about it and provide any supporting evidences if possible. Such cases will be analyzed by our ML-algorithm and implemented in our database, which will improve this summary.
Total investments 12
Average round size
The average size of a deal this fund participated in
Portfolio companies 7
Rounds per year 1.33
Lead investments 4
Follow on index
How often the fund supports its portfolio startups at next rounds
Exits 2
Key employees 5
Stages of investment
Late Stage Venture

Areas of investment

  • Health Care
  • Biotechnology
  • Medical Device
  • Pharmaceutical
  • Therapeutics

The leading representative office of defined VC is situated in the Baltimore. The company was established in North America in United States.

This organization was formed by Kevin Rakin, Matt Zuga, Matt Zuga.

Speaking about the real fund results, this VC is 18 percentage points more often commits exit comparing to other organizations. The high activity for fund was in 2017. The top amount of exits for fund were in 2019. The fund is generally included in less than 2 deals every year. This HighCape Partners works on 16 percentage points less the average amount of lead investments comparing to the other organizations. The common things for fund are deals in the range of 5 - 10 millions dollars.

The typical case for the fund is to invest in rounds with 2-3 participants. Despite the HighCape Partners, startups are often financed by MVM Life Science Partners, Connecticut Innovations, XSeed Capital. The meaningful sponsors for the fund in investment in the same round are MVM Life Science Partners, Connecticut Innovations, Stonehenge Capital. In the next rounds fund is usually obtained by MVM Life Science Partners, Springfield Investments, Robert Bosch Venture Capital.

For fund there is a match between the country of its foundation and the country of its the most frequent investments - United States. The fund has exact preference in a number of founders of portfolio startups. Among the most popular fund investment industries, there are Wellness, Fitness. Besides, a startup requires to be at the age of 6-10 years to receive the investment from the fund. Among the various public portfolio startups of the fund, we may underline Zipline Medical, Cybrexa Therapeutics, Aziyo Biologics

Read more

Look at other 50 related and similar funds Collapse list
Fund NameLocation
AltCity Beirut, Beyrouth, Lebanon
Amerihealth -
Break Trail Ventures Boulder, Colorado, United States
Bryan Garnier & Co France, Ile-de-France, Paris
Cobalt Networks California, Mountain View, United States
Forum Equity Partners Canada, Ontario, Toronto
Gabelhorn Investment Central, Central Region, Singapore
Hydra Ventures -
InnoSpring China, Shanghai
Ironfire Ventures China, Hong Kong, Hong Kong Island
Jollychic China, Hangzhou, Zhejiang
Lightspeed India Partners Delhi, India, New Delhi
Novotech Investments Newcastle upon Tyne, North East, United Kingdom
Praxis Capital Partners -
Revera Home Health Business -
Seoul Business Agency Seoul, Seoul-t'ukpyolsi, South Korea
Stone Ventures United Kingdom, Worcester, Worcestershire
The Worldbeat Center California, San Diego, United States
Tranquility Capital Lidköping, Sweden, Vastra Gotaland
Women's World Banking New York, New York, United States

Notable deals

CompanyIndustryRound SizeDateInvestorsLocation


Health Care
Medical Device
Personal Health
$25M03 Nov 2021 New Haven, Connecticut, United States

Cybrexa Therapeutics

$25M10 Mar 2021 New Haven, Connecticut, United States

Alphina Therapeutics

Health Care
Life Science
15 Dec 2020 Westport, Connecticut, United States

Flyp Nebulizer

Health Care
Medical Device
$4M27 Sep 2019 Fairfield, Connecticut, United States


Health Care
Medical Device
Personal Health
$14M26 Sep 2019 New Haven, Connecticut, United States

Cybrexa Therapeutics

$13M21 Jun 2019 New Haven, Connecticut, United States

Zipline Medical

Health Care
Medical Device
Medical Supplies
Surgical Devices
Therapeutic Devices
$9M19 Jun 2018 California, United States

Cheetah Medical

Developer Platform
Diagnostic Equipment
Monitoring Equipment
$11M12 Sep 2017 Newton, Massachusetts, United States

Cybrexa Therapeutics

$6M16 Jun 2017 New Haven, Connecticut, United States
Cybrexa Therapeutics Completes $25M Series B Financing

– Cybrexa Therapeutics from New Haven develops a new class of therapeutics through its alphalex™ Peptide Drug Conjugate (PDC) tumor targeting platform.
– The company completed its $25m Series B financing.
– Backers included HighCape Capital and new investor Elm Street Ventures.
– The new investment will be aimed at planned advancement of its lead candidate CBX-12 (alphalex™-exatecan) into the clinic.


  • No reviews are submitted yet.
Do you want more?
We provide dozens of additional datapoints about this fund.
Sign up and get access to full fund profile and advanced analysis.
Full team
Industries heatmap
Stages heatmap
Georgaphy breakdown
Portfolio analysis
Performance indexes
Latest highlights
Unlock all data
Do you represent HighCape Partners?
Get access to manage this page
Get in touch
Found incorrect info? Let us know!

You can raise money with us faster

Get matched with relevant funds

Find decision makers data

Connect with investors by email

Remind me later
...and save more than 200 hours*
*-Our recommendation and outreach system saves up to 200 hours of founder time on fundraising for seed and series A+ startups
We use LinkedIn only to verify your account. We don't import or message your contacts, nor post on your behalf.
By creating an account, you agree to our Terms of Service and Privacy Policy.
Crunchbase icon

Content report

The following text will be sent to our editors: